The recent decision by the U.S. Department of Health and Human Services (HHS) to appeal a district court ruling on the use of online tracking technologies in healthcare has sent ripples through the industry. This legal battle pits concerns about patient data privacy against the operational needs of
Medicare, the federal health insurance program designed to serve individuals aged 65 and older, faces substantial financial challenges that are growing increasingly severe. Recently, a spotlight has been placed on the potential repercussions of including semaglutide, a high-cost medication
Johnson & Johnson (J&J), one of the leading pharmaceutical companies globally, has announced significant changes to its participation in the 340B drug discount program. Effective October 15, the company will cease providing upfront discounts on two key drugs and move to a rebate system
As the end of 2024 approaches, the 118th Congress and various executive agencies in the United States are in a heated race to finalize significant health technology policies. This effort spans telehealth policies, health data privacy, cybersecurity, healthcare Artificial Intelligence (AI), and
In recent years, the intersection of music and technology has opened new avenues for healthcare, particularly in the treatment of dementia patients. The integration of these fields promises not only to alleviate symptoms but also to enhance the quality of life for affected individuals. One
Guidehealth, a burgeoning HealthTech company specializing in care coordination to enhance value-based care systems, has recently achieved a significant milestone by securing $14 million in a seed funding round. This funding round is a testament to the company's innovative approach in utilizing
